3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Nasopharyngeal Carcinoma
19
Triple Negative Breast Neoplasms
11
Breast Neoplasms
10
Carcinoma, Non-Small-Cell Lung
7
Head and Neck Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Colorectal Neoplasms
5
Advanced Solid Tumor
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
4
Esophageal Squamous Cell Carcinoma
4
Carcinoma, Transitional Cell
4
Carcinoma, Renal Cell
4
Solid Tumor
3
Small Cell Lung Carcinoma
3
Recurrence
3
Rectal Neoplasms
3
Nasopharyngeal Neoplasms
3
Turcot syndrome
2
Sarcoma
2
Ovarian Neoplasms
2
Oropharyngeal Neoplasms
2
Neoplasm Metastasis
2
Microsatellite Stable Metastatic Colorectal Cancer
2
Locally Advanced Rectal Cancer
2
Liposarcoma
2
Laryngeal Neoplasms
2
Gestational Trophoblastic Disease
2
Esophageal Neoplasms
2
Interventions
toripalimab
2
pembrolizumab
2
Celecoxib
2
sintilimab
1
dostarlimab
1
camrelizumab
1
Radiation Dose Hypofractionation
1
Nivolumab
1
Neoadjuvant Therapy
1
Ipilimumab
1
Interleukin-2
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Turcot syndrome
×
toripalimab
×
Clear all
NCT06903858
2026-05-22
PICC-3
Sun Yat-sen University
Phase 2
Recruiting
105 enrolled
NCT03926338
2025-11-20
PICC
Sun Yat-sen University
Phase 2
Recruiting
270 enrolled